HeartSciences issues $3.6M 12% promissory note to Streeterville Capital, netting $3M

HeartSciences Inc.

Company entered Note Purchase Agreement with Streeterville Capital for $3,605,000 promissory note, netting $3,000,000 after $600,000 OID and $5,000 expenses.
Note bears 12% annual interest and matures 18 months from January 13, 2026.
Streeterville may require monthly redemptions up to $405,000 starting six months after issuance; balance increases 5% if not reduced by $1.25M within 12 months.
Note contains customary covenants and events of default; upon default, interest accrues at up to 18% per annum.
Issued in unregistered private placement under Section 4(a)(2) of Securities Act, relying on accredited investor exemption.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

HeartSciences Inc. incurred senior notes of $3,605,000 with Streeterville Capital, LLC at 12% per annum maturing 18 months after its issuance date.

Instrument: senior notes
Principal: $3,605,000
Counterparty: Streeterville Capital, LLC
Rate: 12% per annum
Maturity: 18 months after its issuance date
Event: incurrence

Exact text from the filing

On January 13, 2026, HeartSciences Inc. (the “Company” entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with Streeterville Capital, LLC, an institutional investor (“Streeterville”), pursuant to which Streeterville purchased from the Company an unsecured promissory note in the amount of $3,605,000 (the “Note”)

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HeartSciences Inc. entered into Note Purchase Agreement with Streeterville Capital, LLC valued at $3,605,000 (effective 2026-01-13).

Action: entry
Agreement: notes offering
Counterparty: Streeterville Capital, LLC
Value: $3,605,000
Effective: 2026-01-13

Exact text from the filing

On January 13, 2026, HeartSciences Inc. (the “Company” entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with Streeterville Capital, LLC, an institutional investor (“Streeterville”), pursuant to which Streeterville purchased from the Company an unsecured promissory note in the amount of $3,605,000

View on SEC.gov

306 debt financings filed in the last 30 days. Browse all debt financings →

HeartSciences Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-005245

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.